Exact Mass: 276.1204824
Exact Mass Matches: 276.1204824
Found 500 metabolites which its exact mass value is equals to given mass value 276.1204824
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sudan_II
C.i. solvent orange 7 appears as red crystals. Insoluble in water. Sudan II is a member of azobenzenes.
Saccharopine
Saccharopine is an intermediate in the degradation of lysine, formed by the condensation of lysine and alpha-ketoglutarate. The saccharopine pathway is the main route for lysine degradation in mammals, and its first two reactions are catalyzed by enzymatic activities known as lysine-oxoglutarate reductase (LOR) and saccharopine dehydrogenase (SDH), which reside on a single bifunctional polypeptide (LOR/SDH) (EC 1.5.1.8). The reactions involved with saccharopine dehydrogenases have very strict substrate specificity for L-lysine, 2-oxoglutarate, and NADPH. LOR/SDH has been detected in a number of mammalian tissues, mainly in the liver and kidney, contributing not only to the general nitrogen balance in the organism but also to the controlled conversion of lysine into ketone bodies. A tetrameric form has also been observed in human liver and placenta. LOR activity has also been detected in brain mitochondria during embryonic development, and this opens up the question of whether or not lysine degradation has any functional significance during brain development. As a result, there is now a new focus on the nutritional requirements for lysine in gestation and infancy. Finally, LOR and/or SDH deficiencies seem to be involved in a human autosomal genetic disorder known as familial hyperlysinemia, which is characterized by serious defects in the functioning of the nervous system and characterized by a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities. Saccharopinuria (high amounts of saccharopine in the urine) and saccharopinemia (an excess of saccharopine in the blood) are conditions present in some inherited disorders of lysine degradation (PMID: 463877, 10567240, 10772957, 4809305). If present in sufficiently high levels, saccharopine can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Saccharopine is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). Many affected children with organic acidemias experience intellectual disability or delayed development. Amino acid from Saccharomyces cerevisiae and Neurospora crassaand is also found in mushrooms and seeds
5-Amino-6-ribitylamino uracil
C9H16N4O6 (276.10697960000005)
5-Amino-6-ribitylamino uracil is an intermediate in riboflavin metabolism. It is converted from 5-amino-6-(5-phosphoribitylamino)uracil via dephosphorylation by the enzyme phosphohistidine phosphatase 1 (EC 3.1.3.-). It is considered to be the second product of the riboflavin synthase reaction (PMID: 14245407). Humans do not have all the enzymes needed to synthesize or metabolize riboflavin. However, gut microflora do have the necessary enzymatic machinery to produce and metabolize this vitamin. Riboflavin (or vitamin B2) is an easily absorbed micronutrient with a key role in maintaining health in humans and animals. It is the central component of the cofactors FAD and FMN, and is therefore required by all flavoproteins. Riboflavin is yellow or yellow-orange in colour and in addition to being used as a food colouring it is also used to fortify some foods including baby foods, breakfast cereals, pastas, sauces, processed cheese, fruit drinks, vitamin-enriched milk products, some energy drinks, and vitamin supplements. 5-amino-6-(d-ribitylamino)uracil, also known as 5-amino-6-ribitylamino-2,4-(1h,3h)pyrimidinedione or 5-arpd, is a member of the class of compounds known as pentoses. Pentoses are monosaccharides in which the carbohydrate moiety contains five carbon atoms. 5-amino-6-(d-ribitylamino)uracil is soluble (in water) and a very weakly acidic compound (based on its pKa). 5-amino-6-(d-ribitylamino)uracil can be found in a number of food items such as radish (variety), chinese cabbage, common beet, and spinach, which makes 5-amino-6-(d-ribitylamino)uracil a potential biomarker for the consumption of these food products. 5-amino-6-(d-ribitylamino)uracil exists in E.coli (prokaryote) and yeast (eukaryote).
Triethyl citrate
Triethyl citrate is used in foods as a flavouring agent, solvent and surface-active agent Triethyl citrate is an ester of citric acid. It is a colorless, odorless liquid used as a food additive (E number E1505) to stabilize foams, especially as whipping aid for egg white. In pharmaceutical coatings and plastics It is used in foods as a flavouring agent, solvent and surface-active agent
Acetylpterosin C
Acetylpterosin C is found in green vegetables. Acetylpterosin C is from Pteridium aquilinum (bracken fern
1-[(2,5-Dimethylphenyl)azo]-2-naphthalenol
1-[(2,5-Dimethylphenyl)azo]-2-naphthalenol is a food dye; delisted for foods by FDA. Food dye; delisted for foods by FDA
N-lactoyl-Tryptophan
N-lactoyl-Tryptophan is lactoyl derivative of tryptophan. N-lactoyl-amino acids are ubiquitous pseudodipeptides of lactic acid and amino acids that are rapidly formed by reverse proteolysis. A protease, cytosolic nonspecific dipeptidase 2 (CNDP2), catalyzes their formation. The plasma levels of these metabolites strongly correlate with plasma levels of lactate and amino acid. (PMID: 25964343)
5-Benzylacyclouridine
D004791 - Enzyme Inhibitors
9-Methoxyellipticine
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines
2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-fluoroaniline
C15H17FN2S (276.10964140000004)
Creatine glutamate
C9H16N4O6 (276.10697960000005)
Etintidine
2-(7'-methylthio)heptylmalate
C12H20O5S (276.10313900000006)
2-(7-methylthio)heptylmalate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 2-(7-methylthio)heptylmalate can be found in a number of food items such as lima bean, redcurrant, butternut, and green zucchini, which makes 2-(7-methylthio)heptylmalate a potential biomarker for the consumption of these food products.
3-(7'-methylthio)heptylmalate
C12H20O5S (276.10313900000006)
3-(7-methylthio)heptylmalate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-(7-methylthio)heptylmalate can be found in a number of food items such as teff, babassu palm, corn, and cauliflower, which makes 3-(7-methylthio)heptylmalate a potential biomarker for the consumption of these food products.
1-(5,7-dihydroxy-2,2,6-trimethyl-2 h -1-benzopyran-8-yl)-2-methyl-1-propanone
(4S,4aR,6R)-1-acetyl-6-(acetyloxy)-4,4a,5,6-tetrahydro-4,7-dimethylnaphthalen-2(3H)-one|eupatorone
Ac-1beta-1-Hydroxy-13-nor-6,9-eremophiladiene-8,11-dione
3-(3-Methyl-2-butenyl)-4-isobutyryloxybenzoic acid
8-hydroxy-3,7-dimethoxy-1,2,3,11a-tetrahydro-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5-one|Methyl-Neotramizin A|Methyl-Neotramizin B
(2E,2E)-4-Me ether,Me ester-3-[4-Hydroxy-3-(4-hydroxy-3-methyl-2-buteny)phenyl]-2-propenoic acid|methyl 3-(4-hydroxyprenyl)-coumarate 4-O-methyl ether
8,12-epoxy-1alpha-methoxy-4alphaH,5alphaH-eudesma-7,11-dien-6,9-dione
6,8-Dimethoxy-3-isobutyl-2-methyl-4H-1-benzopyran-4-one
2,3-Dihydro-5,7-dihydroxy-2,6-dimethyl-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
(S)-Aspertetronin A|2-[(1E,3E)-hexa-1,3-dien-1-yl]-5-methoxy-2-methyl-4-[(2E)-1-oxobut-2-en-1-yl]furan-3-(2H)-one|aspertetronin A
9-Methoxyellipticine
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines
2-Methyl-2-isobutyryl-6,7-dimethoxy-2H-1-benzopyran
methyl (4R,5S,6R,7R,11S)-2,9-dioxo-1(10)-aromadendren-12-oate
(+)-(S)-8,9-dihydro-9-phenyl-7H-phenalene-1,2-diol|monolaterol
2,3-Dihydro-5,7-dihydroxy-2,8-dimethyl-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
Chlorajapolide F
3beta-acetoxy-6,9-dien-8-oxoeremophil-12-nor-11-one
2,2-dimethyl-6-hydroxy-8-(3-hydroxy-3-methyl-1E-butenyl)-chromanone
4-hydroxy-2-(3-hydroxy-2-methoxy-3-methyl-butylidene)-3,4-dihydro-2h-naphthalen-1-one
norpinguisone acetate
A natural product found in Porella chilensis and Porella recurva.
(3aR,4S,5aR,10aR,10bR)-3,3a,4,5,5a,9,10,10b-octahydro-3a,4,10b-trimethyl-2H,7H-naphtho[4a,4-b:1,8-b?c?]difuran-2,7-dione|ciliatolide A
3-crotonoyl-5-<(1E,3E)-hexa-1,3-dienyl>-4-methoxy-5-methylfuran-2(5H)-one|iso-aspertetronin A
2-methyl-6-hydroxycyclohexenyl-3-methyl-1-acetophenone ether
3-oxo-8alpha-methoxy-10aH-eremophila-1,7(11)-dien-12,8beta-olide|3-oxo-8alpha-methoxy-10alphaH-eremophila-1,7(11)-dien-12,8beta-olide|8beta-hydroxy-8alpha-methoxy-3-oxo-eremophil-1,7(11)-dien-12-oic acid lactone
13,14,15,16-tetranorlabd-7-en-(19,6beta),(12,17)-diolide|13,14,15,16-tetranorlabd-7-en-16,6beta:12,17-diolide|13,14,15,16-tetranorlabd-7-ene-19,6b:12,17-diolide
2-isopropyl-9S-methoxy-7R-methyl-6,7-dihydro-2H-furo[3,2-h]isochromen-3(9H)-one|ustusorane D
6-Deoxy-2-O-methyl-3-C-methuyltalose, 9CI-1,4-Di-Ac
2,3-Dihydro-6,7-dimethoxy-2-methyl-2-(2-methyl-1-propenyl)-4H-1-benzopyran-4-one
1,6-dichloro-1,6-dimethyl-4-(propan-2-yl)decahydronaphthalene
2-hexyl-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one|5-hydroxy-2-hexyl-7-methoxy-4-chromone
2,2-Dimethyl-5-methoxy-2H-1-benzopyran-6-propionic acid methyl ester
methyl-3-<3,3-dimethyl-3-hydroxyallyl>-p-coumarate-O-methyl ether
3-carboxy-10-(methylsulfanyl)-2-oxodecanoate
C12H20O5S (276.10313900000006)
Triethylcitrate
CONFIDENCE standard compound; INTERNAL_ID 2857 CONFIDENCE standard compound; INTERNAL_ID 8781
Gly Gly Gly Ser
C9H16N4O6 (276.10697960000005)
Gly Gly Ser Gly
C9H16N4O6 (276.10697960000005)
Gly Ser Gly Gly
C9H16N4O6 (276.10697960000005)
Ser Gly Gly Gly
C9H16N4O6 (276.10697960000005)
SC-66
SC66 is an Akt inhibitor, reduces cell viability in a dose- and time-dependent manner, inhibits colony formation and induces apoptosis in hepatocellular carcinoma (HCC) cells.
3-(2-TriMethylsilanyl-ethoxyMethyl)-6-vinyl-3H-[1,2,3]triazolo[4,5-b]pyridine
(1R,5S)-5-(Dimethylphenylsilyl)-2-(hydroxymethyl)-2-cyclopentene-1-carboxylic acid
C15H20O3Si (276.11816500000003)
Taglutimide
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Oxagrelate
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
dimethyl 1-allyl-5,5-difluorocyclohexane-1,3-dicarboxylate
1-(tert-Butoxycarbonyl)-5-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid
2-(4-(PIPERAZIN-1-YL)PHENYL)PYRIMIDINE HYDROCHLORIDE
Urea, N-(3-fluorophenyl)-N-[3-(2-furanyl)-1-methylpropyl]- (9CI)
1-TERT-BUTYL 5-METHYL 1H-INDAZOLE-1,5-DICARBOXYLATE
[(2S)-1-(4-nitrophenyl)pyrrolidin-2-yl]methyl prop-2-enoate
1-Benzyl-3-methylpiperidin-4-ylamine dihydrochloride
1,2:3,4-Di-O-isopropylidene-6-thio-a-D-galactopyranose
C12H20O5S (276.10313900000006)
1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole
C11H16BF3N2O2 (276.12568619999996)
6-t-butyl-4-piperazinothieno[3,2-d]pyrimidine
C14H20N4S (276.14086000000003)
5-ethyl-1-(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione
4-(1-ADAMANTYL)-6-(METHYLTHIO)-1,3,5-TRAZIN-2-AMINE
C14H20N4S (276.14086000000003)
4-(METHYLAMINO)-1-BENZYLPIPERIDINE DIHYDROCHLORIDE
ETHYL 4-(2-HYDROXYPHENYL)-6-METHYL-2-OXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXYLATE
1-Butyl-3-methylimidazolium Trifluoro(trifluoromethyl)borate
Ethyl 4-hydroxy-2-oxo-1-propyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate
3,5-di(pyridin-2-yl)phenylboronic acid
C16H13BN2O2 (276.10700280000003)
5-[(2-methylpropan-2-yl)oxycarbonylamino]-1H-indole-2-carboxylic acid
3-(2,5-dimethylphenyl)-1-phenylpyrazole-4-carbaldehyde
1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(1,1-dimethylethyl)dimethylsilyl]-
C14H20N2O2Si (276.12939800000004)
2-([1,1-BIPHENYL]-4-CARBONYL)-3-(DIMETHYLAMINO)ACRYLONITRILE
(R)-1-Benzyl-3-dimethylaminopyrrolidine Dihydrochloride
6-(3-(6-METHYLPYRIDIN-2-YL)-1H-PYRAZOL-4-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE
Ethambutol hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent Ethambutol dihydrochloride (Emb dihydrochloride) is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases. Target: Antibacterial Ethambutol dihydrochloride (Emb dihydrochloride) directly affects two polymers, arabinogalactan (AG) and lipoarabinomannan (LAM) in Mycobacterium smegmatis. In M. smegmatis, Ethambutol inhibits synthesis of arabinan completely and inhibits AG synthesis most likely as a consequence of this; more than 50\% of the cell arabinan is released from the bacteria following Ethambutol treatment, whereas no galactan is released. Ethambutol main targets against embB gene product in M. avium. Ethambutol induces 60\% changes in the embB gene in M. tuberculosis resistant mutants [1]. Ethambutol dihydrochloride (Emb dihydrochloride) is effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis. Nearly all strains of M. tuberculosis and M. kansasii as well as a number of strains of the M. aviumcomplex (MAC) are sensitive to Ethambutol. [1] Ethambutol dihydrochloride (Emb dihydrochloride) is potency against M. tuberculosis (H37Rv) with MIC of 0.5 μg/mL in vitro [2]. Ethambutol is efficient on treatment of mycobacterial-infected macrophages. When M. tuberculosis infected macrophages are treated with 6 μg/mL Ethambutol, the log CFUs following treatment for 3 days is 4.17, while value in control group is 4.8. The MICs for M. avium (MTCC 1723) and M. smegmatis (MTCC 6) are 15 μg/mL and 0.18 μg/mL, respectively. Ethambutol is efficient in animal model. 100 mg/kg Ethambutol given orally 15 days post i.v. infection 1 ×/week for 5 weeks, induces a lower log CFU compared with untreatment (4.59 vs 5.07) [3].
methyl 2-tert-butyl-5-nitro-1H-indole-7-carboxylate
2-acetamido-3-(6-Methoxy-1H-indol-3-yl)propanoic acid
4-(1-PIPERIDINYLMETHYL)-BENZENEMETHANAMINEDIHYDROCHLORIDE
(3R)-1-benzyl-N,N-dimethylpyrrolidin-3-amine,dihydrochloride
1,2-o-isopropylidene-3-benzyloxy-5,6-dideoxy-glucofuranose
5-tert-butyl-2-[(4-fluorophenyl)methyl]pyrazole-3-carboxylic acid
Tert-butyl 2-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetate
2-Morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethanamine
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine
TERT-BUTYL ((2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)METHYL)CARBAMATE
Y-26763
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
N-(4-TERT-BUTYL-PHENYL)-6-CHLORO-PYRIMIDINE-2,4-DIAMINE
Tris(isopropenyloxy)(phenyl)silane
C15H20O3Si (276.11816500000003)
TERT-BUTYL ((6-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHYL)CARBAMATE
4-(4-CHLOROBENZYL)-3-METHYL-5-((R)-PYRROLIDIN-2-YL)-4H-1,2,4-TRIAZOLE
N-[3-Cyano-3-[4-(dicyanomethyl)phenyl]-2-propenylidene]-N-ethyl-ethaniminium inner salt
(3S,5R)-tert-Butyl4-(chlorocarbonyl)-3,5-dimethylpiperazine-1-carboxylate
Pyrido[2,1-f]purine-2,4,6(1H,3H,7H)-trione,8,9-dihydro-1,3,8,8-tetramethyl-
C13H16N4O3 (276.12223459999996)
(3R)-3-(tert-Butyldimethylsilyl)oxypentanedioate-1-methyl monoester
5-(2-adamantylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione
1-BENZYL-3-(TERT-BUTYL)-1H-PYRAZOLE-5-CARBONYL CHLORIDE
trimethyl-(2-trimethylsilyl-1-trimethylsilyloxyethenoxy)silane
etintidine
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
1,3-diisocyanato-2-methyl-benzene, 2-methyloxirane, oxirane
5-(3-(1-Methylcyclopropyl)propyl)-1H-pyrano(2,3-d)pyrimidine-2,4,7(3H)-trione
(S)-2-((S)-2-Hydroxypropanamido)-3-(1H-indol-3-yl)propanoic acid
Butanedioic acid, methyl-, bis(trimethylsilyl) ester
(5R,6R,7S,8S)-5-(Hydroxymethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyridine-6,7,8-triol
2,4-Dihydroxy-N-[2-(2-mercapto-vinylcarbamoyl)-ethyl]-3,3-dimethyl-butyramide
2-(7-Methylsulfanylheptyl)-3-oxobutanedioic acid
C12H20O5S (276.10313900000006)
4-methyl-4-sulfanylpentan-2-one-[CysGly] conjugate
2-[[(2R)-2-amino-3-(2-methyl-4-oxopentan-2-yl)sulfanylpropanoyl]amino]acetic acid
4-Amino-5-[2-[carbamimidoyl(methyl)amino]acetyl]peroxy-5-oxopentanoic acid
C9H16N4O6 (276.10697960000005)
4-Amino-5-(2-amino-3-methylpentanoyl)peroxy-5-oxopentanoic acid
(3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoic acid
A diester resulting from the formal sequential esterification of the hydroxy group of one molecule of (3R)-3-hydroxybutyric acid with the carboxy group of a second, followed by the esterification of the hydroxy group of the product with the carboxy group of a third molecule of (3R)-3-hydroxybutyric acid. Isolated from the Japanese inedible mushroom Hypoxylon truncatum and also the sponge-derived actinomycete Micromonospora sp. RV43.
N-(4-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine
1-[4-[(2-Methyl-4-quinolinyl)amino]phenyl]ethanone
5-methyl-3-(2-morpholino-2-oxoethyl)-1,3-benzoxazol-2(3H)-one
5-[(2,4-Diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenol
C13H16N4O3 (276.12223459999996)
N-(2-methoxyethyl)-5-(3-methoxyphenyl)-1,2-oxazole-3-carboxamide
N-(3-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine
(1-Methylsulfonyl-4-piperidinyl)-(4-morpholinyl)methanone
N-cyclohexyl-N,4-dimethyl-5-thieno[3,2-b]pyrrolecarboxamide
5-Amino-1-ethyl-3-(1-naphthalenylmethyl)-4-pyrazolecarbonitrile
6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoic acid
(5R)-5-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoic acid
Ethyl 1,2,7-trimethyl-4-nitro-1H-indole-3-carboxylate
5-Amino-6-(D-ribitylamino)uracil
C9H16N4O6 (276.10697960000005)
An aminouracil that is D-ribitol in which the hydroxy group at position 1 is substituted by the 6-amino group of 5,6-diaminouracil. Early intermediate in bacterial riboflavin synthesis.
2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-fluoroaniline
C15H17FN2S (276.10964140000004)
carboxylato-PTIO
A benzoate that is the conjugate base of carboxy-PTIO, obtained by deprotonation of the carboxy group.
6-hydroxy-8-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-2,2-dimethyl-3h-1-benzopyran-4-one
(4as,8s,10s,10as,10br)-10-hydroxy-8-(hydroxymethyl)-4a,10b-dimethyl-8h,9h,10h,10ah-cyclohexa[f]chromen-1-one
(2r)-1-[(2s)-4,6-dihydroxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]-2-methylbutan-1-one
(2s)-4-[(2e)-but-2-enoyl]-2-[(1e,3e)-hexa-1,3-dien-1-yl]-5-methoxy-2-methylfuran-3-one
(1r,6s,11as,14ar)-1-hydroxy-6-methyl-1h,6h,7h,11ah,12h,14h,14ah-cyclopenta[f]oxacyclotridecane-4,13-dione
4-[(2e)-but-2-enoyl]-2-[(1e,3e)-hexa-1,3-dien-1-yl]-5-methoxy-2-methylfuran-3-one
5-[(5-amino-2,6-dihydroxypyrimidin-4-yl)amino]pentane-1,2,3,4-tetrol
C9H16N4O6 (276.10697960000005)
9a-methoxy-3,4a,5-trimethyl-4h,5h,8ah,9h-naphtho[2,3-b]furan-2,6-dione
(6ar,7s,10as)-7,10a-dimethyl-2-oxo-4h,6h,6ah,8h,9h,10h-cyclohexa[f]isochromene-7-carboxylic acid
(2e)-3-(3,4-dimethoxyphenyl)prop-2-en-1-yl (2e)-2-methylbut-2-enoate
(2r,8s,8ar)-5-acetyl-3,8-dimethyl-6-oxo-2,7,8,8a-tetrahydro-1h-naphthalen-2-yl acetate
1-[(2s)-6,7-dimethoxy-2-methylchromen-2-yl]-2-methylpropan-1-one
(11r,13s)-4-isopropyl-13-methoxy-11-methyl-3,12-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
4-isopropyl-11-methoxy-11-methyl-3,12-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
(2r)-5-hydroxy-2-methyl-2-[(2r,3s)-3-methyl-5-oxooxolan-2-yl]-3h-1-benzopyran-4-one
(3r)-3,6-dihydroxy-8,8-dimethyl-1-oxo-3h,4h,7h,9h-indeno[4,5-c]pyran-5-carbaldehyde
1-(5-hydroxy-7-methoxy-2,2-dimethylchromen-6-yl)-2-methylpropan-1-one
(2e)-3-(3,4-dimethoxyphenyl)prop-2-en-1-yl (2z)-2-methylbut-2-enoate
(1r,2s)-2-hydroxy-2-[(2r)-6-oxo-2,3-dihydropyran-2-yl]-1-phenylethyl acetate
9,9-dimethyl-5-(3-methylbut-3-en-1-yn-1-yl)-2,8-dioxatricyclo[5.4.0.0¹,³]undec-5-ene-4,10-diol
(2r,3r,4s,5s,6r)-2-{[(1r,6s)-6-hydroxycyclohex-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,4s)-4-[(5r)-8-methyl-4,7-dioxo-1,6-dioxaspiro[4.4]nona-2,8-dien-3-yl]cyclohexane-1-carbaldehyde
2-[(2s)-6-acetyl-5-hydroxy-2,3-dihydro-1-benzofuran-2-yl]prop-2-en-1-yl acetate
6-hydroxy-5-methoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-2-one
8-(2,5-dihydroxyphenyl)-6-hydroxy-2,6-dimethylocta-2,7-dienal
(1s,2s,4as,9ar,10s)-1,2,8,10-tetrahydroxy-6-methyl-2,4a,9a,10-tetrahydro-1h-anthracen-9-one
6-hydroxy-3,15-dimethyl-5,14-dioxatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-2,11-diene-4,13-dione
6-(1,2-dihydroxy-3-methylbut-3-en-1-yl)-7-methoxychromen-2-one
2-(6,7-dihydroxy-7-methyl-3-methylideneoct-1-yn-1-yl)benzene-1,4-diol
11β,13-dihydrolactucin
{"Ingredient_id": "HBIN000357","Ingredient_name": "11\u03b2,13-dihydrolactucin","Alias": "NA","Ingredient_formula": "C15H16O5","Ingredient_Smile": "CC1=C2C(C3C(C(C1)O)C(=C)C(=O)O3)C(=CC2=O)CO","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40764","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,4-dihydro-1,2-secomicrominutinin methyl ester
{"Ingredient_id": "HBIN007347","Ingredient_name": "3,4-dihydro-1,2-secomicrominutinin methyl ester","Alias": "NA","Ingredient_formula": "C15H16O5","Ingredient_Smile": "COC(=O)CCC1=C(C2=C(C=C1)OC3C2C(=C)CO3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5710","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3'-(r)-(+)-hamaudol
{"Ingredient_id": "HBIN009582","Ingredient_name": "3'-(r)-(+)-hamaudol","Alias": "3'(r)-(+)-hamaudol","Ingredient_formula": "C15H16O5","Ingredient_Smile": "CC1=CC(=O)C2=C(C3=C(C=C2O1)OC(C(C3)O)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31056;9203","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3'(s)-(?)-hamaudol
{"Ingredient_id": "HBIN009719","Ingredient_name": "3'(s)-(?)-hamaudol","Alias": "NA","Ingredient_formula": "C15H16O5","Ingredient_Smile": "CC1=CC(=O)C2=C(C3=C(C=C2O1)OC(C(C3)O)(C)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15701","TCMID_id": "9204","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-methyoxymarmesin
{"Ingredient_id": "HBIN011826","Ingredient_name": "5-methyoxymarmesin","Alias": "NA","Ingredient_formula": "C15H16O5","Ingredient_Smile": "CC(C)(C1CC2=C(O1)C=C3C(=C2OC)C=CC(=O)O3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14811","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-methoxy-8-(1,4-dihydroxy-3-methyl-2-butenyl)-2h-1-benzopyran-2-one
{"Ingredient_id": "HBIN013321","Ingredient_name": "7-methoxy-8-(1,4-dihydroxy-3-methyl-2-butenyl)-2h-1-benzopyran-2-one","Alias": "NA","Ingredient_formula": "C15H16O5","Ingredient_Smile": "NA","Ingredient_weight": "276.28","OB_score": "NA","CAS_id": "98619-28-4","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7438","PubChem_id": "NA","DrugBank_id": "NA"}
1,5-dihydroxy-3-(hydroxymethyl)-10a-methyl-6,7-dihydro-5h-xanthen-9-one
6-[(2s)-2-hydroperoxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
(4s,11r,13s)-4-isopropyl-13-methoxy-11-methyl-3,12-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
methyl 4-hydroxy-2-{[(3-phenylprop-2-enoyl)oxy]methyl}but-2-enoate
8-[(3,3-dimethyloxiran-2-yl)(hydroxy)methyl]-7-methoxychromen-2-one
methyl 2-[(2r,3r,4as)-3-hydroxy-4a,8-dimethyl-7-oxo-1,2,3,4-tetrahydronaphthalen-2-yl]prop-2-enoate
(2s,3r,3ar,6s)-2,7,8-trihydroxy-3,6,9-trimethyl-2,3,3a,4,5,6-hexahydrophenalen-1-one
methyl (2e)-3-{3-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-4-methoxyphenyl}prop-2-enoate
3-(3-methylbut-2-en-1-yl)-4-[(2-methylpropanoyl)oxy]benzoic acid
methyl (4ar,7s,7ar)-4a,7-dimethyl-4,6-dioxo-5h,7h,8h-indeno[5,6-b]furan-7a-carboxylate
6,8-dimethoxy-2-methyl-3-(2-methylpropyl)chromen-4-one
6-[(2r)-2-hydroperoxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
(2r,3r)-8-hydroxy-3-(hydroxymethyl)-2,3,9-trimethyl-2h-furo[3,2-c]chromen-4-one
(4as,5s,8s,8ar)-8-methoxy-3,5,8a-trimethyl-4ah,5h,6h,7h,8h-naphtho[2,3-b]furan-4,9-dione
1-(2-{[(6s)-6-hydroxy-2-methylcyclohex-1-en-1-yl]oxy}-5-methoxyphenyl)ethanone
(1r,3s,5s,10s,11s)-5-hydroxy-3,7,12-trimethyl-2,9-dioxatetracyclo[9.3.0.0¹,³.0⁶,¹⁰]tetradeca-6,12-diene-8,14-dione
(8s)-8-(2-hydroxypropan-2-yl)-5-methoxy-8h,9h-furo[2,3-h]chromen-2-one
methyl 2-[(5s,6s,7ar)-6-ethenyl-3,6-dimethyl-2-oxo-4,5,7,7a-tetrahydro-1-benzofuran-5-yl]prop-2-enoate
8-(2-hydroxypropan-2-yl)-5-methoxy-8h,9h-furo[2,3-h]chromen-2-one
(3ar,4s,9ar,9br)-4-hydroxy-9-(hydroxymethyl)-6-methyl-3-methylidene-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
(e)-({[(1s,2r,3r)-1-carboxy-2-hydroxy-1,4-dimethylpentan-3-yl]-c-hydroxycarbonimidoyl}methylidene)(methoxy)oxidoazanium
(3r,4s,4as)-4,8,9-trihydroxy-3,4a-dimethyl-3,4-dihydro-2h-xanthen-1-one
methyl (2z,3s,4s,5e)-4-hydroxy-2-(methoxymethylidene)-3-methyl-6-phenylhex-5-enoate
methyl 2-{[4-(formyloxy)phenyl]methylidene}-4-methyl-3-oxopentanoate
8-(3,4-dihydroxy-3-methylbut-1-en-1-yl)-7-methoxychromen-2-one
7-{[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]oxy}-6-methoxychromen-2-one
methyl (2e)-4-hydroxy-2-({[(2e)-3-phenylprop-2-enoyl]oxy}methyl)but-2-enoate
5,7-dihydroxy-8-(4-hydroxy-3-methylbut-2-en-1-yl)-2-methylchromen-4-one
5,7-dihydroxy-6-[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]-2-methylchromen-4-one
(3as,4r,4as,9as)-4-hydroxy-5-(hydroxymethyl)-8-methyl-3-methylidene-3ah,4h,4ah,9h,9ah-azuleno[6,5-b]furan-2,7-dione
5-acetyl-3,8-dimethyl-6-oxo-2,7,8,8a-tetrahydro-1h-naphthalen-2-yl acetate
7-[(4-hydroxy-3-methylbut-2-en-1-yl)oxy]-6-methoxychromen-2-one
1-methyl-5-{9h-pyrido[3,4-b]indole-1-carbonyl}imidazole
(1s,3s,6s,10r,11s)-3,11-dimethyl-7-methylidene-2,9,12-trioxatetracyclo[9.4.0.0¹,³.0⁶,¹⁰]pentadec-14-ene-8,13-dione
3-(3,4-dimethoxyphenyl)prop-2-en-1-yl 2-methylbut-2-enoate
(1s,2s,3r)-2,8-dihydroxy-1-(hydroxymethyl)-3-methyl-1,2,3,4-tetrahydroxanthen-9-one
methyl 8-(acetyloxy)-2,2-dimethylchromene-6-carboxylate
8-[(1z,3s)-3,4-dihydroxy-3-methylbut-1-en-1-yl]-7-methoxychromen-2-one
2-(4-hydroxyphenyl)ethyl 2-(4-oxo-5,6-dihydropyran-3-yl)acetate
methyl (2e,3r,4s,5e)-4-hydroxy-2-(methoxymethylidene)-3-methyl-6-phenylhex-5-enoate
8-hydroxy-3-(hydroxymethyl)-2,3,9-trimethyl-2h-furo[3,2-c]chromen-4-one
2-[(2r,3r)-5-acetyl-3-hydroxy-2,3-dihydro-1-benzofuran-2-yl]prop-2-en-1-yl acetate
6,7-dimethoxy-2-methyl-2-(2-methylprop-1-en-1-yl)-3h-1-benzopyran-4-one
1-[4,6-dihydroxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]-2-methylbutan-1-one
4,8,9-trihydroxy-3,4a-dimethyl-3,4-dihydro-2h-xanthen-1-one
7,8-dihydroxy-6-methoxy-5-(3-methylbut-2-en-1-yl)chromen-2-one
(1s)-6,8-dihydroxy-1-methyl-5-(3-methylbut-2-en-1-yl)-1h-isochromene-3,7-dione
(1r,4s,6s,13r,14r)-6,11-dimethyl-5,9,15,17-tetraoxapentacyclo[11.2.2.0¹,¹⁴.0⁴,⁶.0⁸,¹²]heptadeca-8(12),10-dien-16-one
(3r)-3-[(3-{[(3r)-3-hydroxybutanoyl]oxy}butanoyl)oxy]butanoic acid
8-(1-hydroxy-3-methyl-2-oxobutyl)-7-methoxychromen-2-one
(1r,3r,4as,5r,7s,7as)-3,4a,5-trihydroxy-1-methoxy-7-methyl-hexahydrocyclopenta[c]pyran-7-yl acetate
(1'r,2r,5'r,8'r)-3',4'-dimethyl-11'-oxo-10'-oxaspiro[oxirane-2,12'-tricyclo[6.4.0.0¹,⁵]dodecane]-3',6'-diene-7'-carboxylic acid
4-hydroxy-2-[2-(4-hydroxyphenyl)ethyl]-6-oxocyclohex-1-ene-1-carboxylic acid
8-[(2s,3s)-3-(2-hydroxypropan-2-yl)oxiran-2-yl]-7-methoxychromen-2-one
2-hydroxy-4,8,8-trimethyl-4h,9h,10h-pyrano[3,2-f]isochromene-5,6-dione
2-(6-acetyl-5-hydroxy-2,3-dihydro-1-benzofuran-2-yl)prop-2-en-1-yl acetate
3-(3-hydroxy-2-methoxy-5-methylphenoxy)-5-methylbenzene-1,2-diol
5,5-dimethyl-11,13-dioxatetracyclo[7.6.0.0¹,¹².0²,⁷]pentadec-2(7)-ene-3,8,14-trione
(2e,4e,6e,8e,10e)-12-methoxy-3,5,9-trimethyl-12-oxododeca-2,4,6,8,10-pentaenoic acid
(2s,3r,4s,5r,6r)-2-{[(1r,4r)-4-hydroxy-1-methylcyclopent-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
4-[4-methyl-5-(4-methylfuran-2-yl)-5-oxopent-3-en-1-yl]-2,6-dioxabicyclo[3.1.0]hexan-3-one
methyl 3-(5-methoxy-2,2-dimethylchromen-6-yl)propanoate
8-[(1r,2s)-1,2-dihydroxy-3-methylbut-3-en-1-yl]-7-methoxychromen-2-one
1-(6,7-dimethoxy-2-methylchromen-2-yl)-2-methylpropan-1-one
9-hydroxy-10-methoxy-8,8-dimethyl-9h,10h-pyrano[2,3-h]chromen-2-one
5-hydroxy-3,7,12-trimethyl-2,9-dioxatetracyclo[9.3.0.0¹,³.0⁶,¹⁰]tetradeca-6,12-diene-8,14-dione
5-acetyl-2-(3-hydroxyprop-1-en-2-yl)-2,3-dihydro-1-benzofuran-3-yl acetate
(1r,2r,6s,8e,11s)-11-hydroxy-8-methyl-3-methylidene-5,14-dioxatricyclo[10.2.1.0²,⁶]pentadeca-8,12(15)-diene-4,13-dione
(1r,2r)-2-hydroxy-2-[(2r)-6-oxo-2,3-dihydropyran-2-yl]-1-phenylethyl acetate
methyl 4-hydroxy-2-(methoxymethylidene)-3-methyl-6-phenylhex-5-enoate
8-[(1z,3r)-3,4-dihydroxy-3-methylbut-1-en-1-yl]-7-methoxychromen-2-one
(3as,5s,5as,9ar)-3a-methoxy-1,5,8-trimethyl-4h,5h,5ah,6h,9ah-naphtho[2,1-b]furan-2,7-dione
(6s,8r)-6,10,11-trihydroxy-4,8,12-trimethyl-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraen-3-one
8-{[(2s)-3,3-dimethyloxiran-2-yl]methoxy}-7-methoxychromen-2-one
5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-trien-13-one
4-{5-[(1e)-2-carboxy-2-methyleth-1-en-1-yl]furan-3-yl}cyclohex-1-ene-1-carboxylic acid
(2e)-8-(2,5-dihydroxyphenyl)-6-hydroxy-2,6-dimethylocta-2,7-dienal
4-[(1r)-1-hydroxy-3-methylbutyl]-2h-[1,3]dioxolo[4,5-g]chromen-6-one
(2r,3s,4s)-5-[(5-amino-2,6-dihydroxypyrimidin-4-yl)amino]pentane-1,2,3,4-tetrol
C9H16N4O6 (276.10697960000005)